ESR1 and melanoma: On one hand, a recent publication describes nidogen-1 as a promoter of metastasis to the lung in a breast cancer and melanoma model and high expression of nidogen-1 to correlate with an unfavourable prognosis in estrogen receptor negative breast cancer [47].